Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O I Epstein

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Bulletin of Experimental Biology and Medicine|August 15, 2009
Mutagenic activity of potentiated antibodies to erythropoietinO L Voronova, O P Rogozina, Yu L Dugina, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 14, 2016
[Antiamnesic effects divaza and its component model β-amyloid amnesia]K K Ganinа, Yu L Duginа, E S Zhavbert, et al.
Bulletin of Experimental Biology and Medicine|September 2, 2003
Effect of antibodies to histamine in ultralow doses on production of allergen-specific antibodiesV I Agafonov, N V Bel'skaya, M G Danilets, et al.
Bulletin of Experimental Biology and Medicine|December 2, 2008
Study of the correlation between clinical efficiency of impaza and serum ADMA levelE S Zhavbert, S A Tarasov, J L Dugina, et al.
Bulletin of Experimental Biology and Medicine|July 20, 2005
Neuroprotective activity of proproten in rats with experimental local photothrombosis of the prefrontal cortexG A Romanova, T A Voronina, Yu L Dugina, et al.
Bulletin of Experimental Biology and Medicine|February 2, 2008
Involvement of the serotoninergic system in the mechanism of action of ultralow dose antibodies to S-100 proteinI A Kheifets, Yu L Dugina, T A Voronina, et al.
International Journal of Tissue Reactions|April 26, 2005
A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-alpha and diclofenac in rheumatoid arthritisJ L Dugina, V I Petrov, A R Babayeva, et al.
Bulletin of Experimental Biology and Medicine|February 8, 2008
Study of antidiabetic activity of a new ultralow-dose antibody preparation on the model of streptozotocin diabetes in ratsA A Spasov, M P Samokhina, I A Kheyfets, et al.
Frontiers in Bioscience : a Journal and Virtual Library|April 18, 2003
Membrane and synaptic effects of anti-S-100 are prevented by the same antibodies in low concentrationsO I Epstein, A Beregovoy, N S Sorokina, et al.
Bulletin of Experimental Biology and Medicine|April 17, 2010
Changes in electrical properties of command neurons during protective effect of low doses of antibodies to S100 protein on the development of long-term sensitization in Helix lucorumA Kh Timoshenko, V V Andrianov, T Kh Gainutdinova, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Bulletin of Experimental Biology and Medicine|August 15, 2009
Mutagenic activity of potentiated antibodies to erythropoietinO L Voronova, O P Rogozina, Yu L Dugina, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 14, 2016
[Antiamnesic effects divaza and its component model β-amyloid amnesia]K K Ganinа, Yu L Duginа, E S Zhavbert, et al.
Bulletin of Experimental Biology and Medicine|September 2, 2003
Effect of antibodies to histamine in ultralow doses on production of allergen-specific antibodiesV I Agafonov, N V Bel'skaya, M G Danilets, et al.
Bulletin of Experimental Biology and Medicine|December 2, 2008
Study of the correlation between clinical efficiency of impaza and serum ADMA levelE S Zhavbert, S A Tarasov, J L Dugina, et al.
Bulletin of Experimental Biology and Medicine|July 20, 2005
Neuroprotective activity of proproten in rats with experimental local photothrombosis of the prefrontal cortexG A Romanova, T A Voronina, Yu L Dugina, et al.
Bulletin of Experimental Biology and Medicine|February 2, 2008
Involvement of the serotoninergic system in the mechanism of action of ultralow dose antibodies to S-100 proteinI A Kheifets, Yu L Dugina, T A Voronina, et al.
International Journal of Tissue Reactions|April 26, 2005
A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-alpha and diclofenac in rheumatoid arthritisJ L Dugina, V I Petrov, A R Babayeva, et al.
Bulletin of Experimental Biology and Medicine|February 8, 2008
Study of antidiabetic activity of a new ultralow-dose antibody preparation on the model of streptozotocin diabetes in ratsA A Spasov, M P Samokhina, I A Kheyfets, et al.
Frontiers in Bioscience : a Journal and Virtual Library|April 18, 2003
Membrane and synaptic effects of anti-S-100 are prevented by the same antibodies in low concentrationsO I Epstein, A Beregovoy, N S Sorokina, et al.
Bulletin of Experimental Biology and Medicine|April 17, 2010
Changes in electrical properties of command neurons during protective effect of low doses of antibodies to S100 protein on the development of long-term sensitization in Helix lucorumA Kh Timoshenko, V V Andrianov, T Kh Gainutdinova, et al.
Pageof 11